Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
1 hedge funds and large institutions have $31 invested in Immunogen Inc in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
67% less funds holding
Funds holding: 3 → 1 (-2)
100% less capital invested
Capital invested by funds: $27.8K → $31 (-$27.7K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IA
IFP Advisors
Tampa,
Florida
|
-$25.9K |
| 2 |
MG
Mather Group
Chicago,
Illinois
|
-$1.84K |
IMGN Hedge Fund Activity: Q2 2024 in Review
1 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2024, worth a combined $31 — down 100% from $27.8K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of IMGN and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was IFP Advisors, exiting entirely with an estimated $25.9K sold.
- 1 institutional investor held Immunogen Inc (IMGN) as of Q2 2024, down from 3 in Q1 2024.
- Funds reported $31 of Immunogen Inc stock for Q2 2024, down 100% quarter-over-quarter.
- 0 funds opened new Immunogen Inc positions in Q2 2024 and 2 closed out, a net change of -2 holders.
- The largest Immunogen Inc seller in Q2 2024 was IFP Advisors, an estimated $25.9K sold.
Based on aggregated 13F filings for Q2 2024.